- Home
- IPW vs CDIO Comparison
IPW vs CDIO Comparison
Compare IPW & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPW
- CDIO
- Stock Information
- Founded
- IPW 2018
- CDIO 2017
- Country
- IPW United States
- CDIO United States
- Employees
- IPW N/A
- CDIO N/A
- Industry
- IPW Catalog/Specialty Distribution
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- IPW Consumer Discretionary
- CDIO Health Care
- Exchange
- IPW Nasdaq
- CDIO Nasdaq
- Market Cap
- IPW 17.1M
- CDIO 19.5M
- IPO Year
- IPW 2021
- CDIO N/A
- Fundamental
- Price
- IPW $0.62
- CDIO $4.53
- Analyst Decision
- IPW Strong Buy
- CDIO Buy
- Analyst Count
- IPW 1
- CDIO 1
- Target Price
- IPW $2.75
- CDIO $2.00
- AVG Volume (30 Days)
- IPW 32.7K
- CDIO 68.6K
- Earning Date
- IPW 05-15-2025
- CDIO 05-23-2025
- Dividend Yield
- IPW N/A
- CDIO N/A
- EPS Growth
- IPW N/A
- CDIO N/A
- EPS
- IPW N/A
- CDIO N/A
- Revenue
- IPW $80,844,081.00
- CDIO $34,890.00
- Revenue This Year
- IPW $8.31
- CDIO $1,434.82
- Revenue Next Year
- IPW $77.15
- CDIO $4,661.91
- P/E Ratio
- IPW N/A
- CDIO N/A
- Revenue Growth
- IPW N/A
- CDIO 104.45
- 52 Week Low
- IPW $0.41
- CDIO $0.19
- 52 Week High
- IPW $3.65
- CDIO $1.77
- Technical
- Relative Strength Index (RSI)
- IPW 58.59
- CDIO 29.92
- Support Level
- IPW $0.52
- CDIO $4.50
- Resistance Level
- IPW $0.65
- CDIO $14.46
- Average True Range (ATR)
- IPW 0.05
- CDIO 1.69
- MACD
- IPW 0.00
- CDIO -0.97
- Stochastic Oscillator
- IPW 76.92
- CDIO 4.66
About IPW iPower Inc.
iPower Inc is online hydroponic equipment and accessory retailer and supplier in North America. The company sells products through own website as well as online channel partners that include Amazon, Walmart, and eBay.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.